On April 20, a popular day for cannabis enthusiasts, headlines were filled with pot puns, promises of legalization from politicians and an announcement that Albuquerque ended criminal penalties for possession of small amounts of marijuana. But after the smoke cleared, some medical cannabis advocates are still holding their breath, waiting to hear from New Mexico’s top medical cannabis decision maker on whether or not opioid addicts can legally obtain derivatives of the plant to aid in trying to defeat an opioid addiction. New Mexico Department of Health Secretary Lynn Gallagher is expected to decide soon whether to accept or reject, for the third time, a recommendation from a board of medical professionals to add opioid use disorder to the list of 21 conditions that currently qualify someone to be a part of the state’s medical cannabis program. Gallagher has not indicated publicly if she will add opioid use disorder to the list of qualifying conditions. Documents obtained by NM Political Report, through an Inspection of Public Records Act request, show staff discussions about recommended conditions an advisory board sent to Gallagher.
New Mexico lawmakers injected a dose of political pressure Monday into an unwavering but so far unsuccessful effort to add opioid use disorder to the list of qualifying conditions for medical cannabis in New Mexico. State Sen. Jeff Steinborn and Rep. Joanne Ferrary, both Democrats from Las Cruces, held a news conference at the Roundhouse to bring attention to companion memorials they are sponsoring, calling on Department of Health Secretary Lynn Gallagher to allow people with opioid dependence to obtain medical marijuana to help them break the chains of their addiction. “It is past time that this secretary do this,” Steinborn said. “People are dying every day in the state of New Mexico from opioid abuse, and medical marijuana has proven to be a safer treatment for any underlying conditions and certainly, hopefully, to step people down from opioid addiction into something safer that won’t kill them.” Twice, the state Medical Cannabis Program’s advisory board has recommended medical marijuana be allowed as a treatment for opioid addiction.
A prominent medical cannabis producer in New Mexico filed a federal lawsuit against officials with the state agency that oversees the New Mexico State Fair and owns the fairgrounds. In the complaint filed Wednesday, New Mexico Top Organics-Ultra Health accused top staffers with Expo New Mexico along with the chair of the state fair board of violating the First and Fourteenth Amendments of the U.S. Constitution for barring the medical cannabis company from bringing cannabis-related materials to an educational booth later this year. Chairman of the New Mexico State Fair Commission Larry Kennedy, Expo New Mexico General Manager Dan Mourning and Concessions Department Director Raina Bingham are named as defendants in the case. The state fair officials, according to the lawsuit, “implicitly chilled” Ultra Health’s “clearly established rights to freedom of speech and expression.” New Mexico Expo officials, though, said they have the authority to implement their own rules and regulations.
Keeping tabs on the amount of medical cannabis available throughout the state may seem straightforward, but a review of quarterly reports seem to show more cannabis available for sale than what was grown or produced. While the state’s Department of Health requires producers to accurately track every gram of cannabis—beginning with harvesting and ending with sales—reports from some producers appear to have glaring discrepancies. Through a review of quarterly reports, NM Political Report found that at least five medical cannabis producers who reported sales exceeding the amount of cannabis that they produced. Those five producers reported selling a combined 676,272 grams of cannabis between January and March, but should have only had a combined 475,028 grams available to sell during that period. This means more than 200,000 grams, or 44 pounds, of medical cannabis sold in New Mexico in three months with almost no accounting of where it came from.
A prominent Albuquerque medical cannabis producer will not have to shut its doors next week during what he says is one of his busiest days of the year. This comes after Santa Fe Judge David Thompson ruled Monday that Ultra Health must pay a $100 fine for bringing a cannabis seedling plant to the New Mexico State Fair last year. But Ultra Health will not have to close down for five days, as the state originally ordered to punish the medical cannabis producer for putting the plant on public display. The ruling comes after a nearly seven-month long legal battle between the company and the New Mexico Department of Health. Ultra Health brought a non flowering cannabis plant to the New Mexico State Fair in September 2016 and was quickly told to remove it by fair officials.
A New Mexico state agency and a medical cannabis company argued in a state district court Monday morning whether the state’s punishment of the company was warranted. Santa Fe District Court Judge David Thompson heard from both the state’s Department of Health (DOH) and a lawyer representing medical cannabis producer New Mexico Top Organics-Ultra Health about whether the company will have to shut down retail operations for five days later this month. The department claims Ultra Health violated the state’s medical cannabis program rules by moving a plant out of their approved growing and retail facilities and into the public. The pending sanction is a result of a cannabis plant Ultra Health used in an exhibit at the New Mexico State Fair last September. The plant Ultra Health brought to the State Fair was non-flowering, meaning it was not mature enough to be used for consumption..
In New Mexico, lawmakers have debated acceptable uses of medical marijuana and some have questioned if cannabis producers are allowed to have enough medical cannabis to qualify as an “adequate supply” for patients. While politicians and medical cannabis advocates in Santa Fe argue over appropriate plant numbers, getting actual numbers from the agency that governs the program is difficult—despite the fact that producers are required to use specific software to track all transactions. Despite the plethora of debates and discussion, cannabis transaction data from the state is either unavailable or state employees do not know how to access it. In almost every legislative discussion about New Mexico’s Medical Cannabis Program, producers and patients sell their respective claims on how much medical cannabis should be available in the state. Depending on what day and who is speaking, the state could be in a shortage that amounts to a crisis or have such a glut of cannabis that producers have to unload product to each other.
Eight years ago, Sean Gabaldon didn’t think too much about cancer. As a high school basketball coach he strived to be an example of health to the boys on his team. One day he went to urgent care because his body felt as if he had “done a bunch of sit ups.” After a series of scans that day, doctors diagnosed Gabaldon with stage-four Burkitt lymphoma, a rare form of cancer. Gabaldon never went back to work as a teacher and coach after that initial diagnosis. “It moved so quick, I literally went home for the weekend and never came back,” Gabaldon said.
The state Department of Health was in the hot seat at an interim legislative committee meeting—despite the fact no one from the department was actually in the room. The interim Disabilities Concerns Subcommittee met with a number of people involved with the state’s medical cannabis program. The topic of discussion was the renewal and issuance of patient cards. No representative from DOH showed up, even though the department oversees the program. The committee’s vice chair, Sen. Nancy Rodriguez, D-Santa Fe, expressed her concern that DOH was unable to send anyone to speak about the delays many patients are seeing when applying for medical cannabis cards.
State Auditor Tim Keller wants answers from the state Department of Health for delays in the processing of cards for medical cannabis program patients. In a letter to DOH Secretary-designate Lynn Gallagher sent yesterday, Keller writes that that his office will audit the department’s compliance with the legally-required 30-day waiting period for processing applications of new and returning medical cannabis patients. Patients are required to renew their cards every year. As NM Political Report and other news outlets have recently reported, thousands of patients are waiting as much as two or three times the required time period to receive their card, despite a state statute requiring the department to process applications in no longer than 30 days. Patients waiting in the limbo period aren’t legally allowed to buy cannabis, even if they were members of the program and have been prescribed cannabis by their doctors.